These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 319054)

  • 1. Homologous and heterologous protection of mice with group A streptococcal M protein vaccines.
    Wittner MK; Fox EN
    Infect Immun; 1977 Jan; 15(1):104-8. PubMed ID: 319054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic peptide vaccine against mucosal colonization by group A streptococci. I. Protection against a heterologous M serotype with shared C repeat region epitopes.
    Bessen D; Fischetti VA
    J Immunol; 1990 Aug; 145(4):1251-6. PubMed ID: 1696296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multivalent group A streptococcal vaccine designed to optimize the immunogenicity of six tandem M protein fragments.
    Dale JB
    Vaccine; 1999 Jan; 17(2):193-200. PubMed ID: 9987154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human immune response to immunization with a structurally defined polypeptide fragment of streptococcal M protein.
    Beachey EH; Stollerman GH; Johnson RH; Ofek I; Bisno AL
    J Exp Med; 1979 Oct; 150(4):862-77. PubMed ID: 390084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigenicity of the M proteins of group A hemolytic streptococci: further evidence for shared determinants among serotypes.
    Wittner MK
    Infect Immun; 1976 Feb; 13(2):634-42. PubMed ID: 57101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hybridoma antibodies against protective and nonprotective antigenic determinants of a structurally defined polypeptide fragment of streptococcal M protein.
    Hasty DL; Beachey EH; Simpson WA; Dale JB
    J Exp Med; 1982 Apr; 155(4):1010-8. PubMed ID: 6174666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sortase A induces Th17-mediated and antibody-independent immunity to heterologous serotypes of group A streptococci.
    Fan X; Wang X; Li N; Cui H; Hou B; Gao B; Cleary PP; Wang B
    PLoS One; 2014; 9(9):e107638. PubMed ID: 25232948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Demonstration of protection in mice from a lethal challenge of three M serotypes of Streptococcus pyogenes using an M-negative vaccine.
    Chappell JD; Stuart JG
    Vaccine; 1993; 11(6):643-8. PubMed ID: 8322487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epitopes of group A streptococcal M protein that evoke cross-protective local immune responses.
    Bronze MS; Courtney HS; Dale JB
    J Immunol; 1992 Feb; 148(3):888-93. PubMed ID: 1370521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New multi-determinant strategy for a group A streptococcal vaccine designed for the Australian Aboriginal population.
    Brandt ER; Sriprakash KS; Hobb RI; Hayman WA; Zeng W; Batzloff MR; Jackson DC; Good MF
    Nat Med; 2000 Apr; 6(4):455-9. PubMed ID: 10742155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum opacity factor (SOF) of Streptococcus pyogenes evokes antibodies that opsonize homologous and heterologous SOF-positive serotypes of group A streptococci.
    Courtney HS; Hasty DL; Dale JB
    Infect Immun; 2003 Sep; 71(9):5097-103. PubMed ID: 12933852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differing Efficacies of Lead Group A Streptococcal Vaccine Candidates and Full-Length M Protein in Cutaneous and Invasive Disease Models.
    Rivera-Hernandez T; Pandey M; Henningham A; Cole J; Choudhury B; Cork AJ; Gillen CM; Ghaffar KA; West NP; Silvestri G; Good MF; Moyle PM; Toth I; Nizet V; Batzloff MR; Walker MJ
    mBio; 2016 Jun; 7(3):. PubMed ID: 27302756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intranasal immunization with multivalent group A streptococcal vaccines protects mice against intranasal challenge infections.
    Hall MA; Stroop SD; Hu MC; Walls MA; Reddish MA; Burt DS; Lowell GH; Dale JB
    Infect Immun; 2004 May; 72(5):2507-12. PubMed ID: 15102757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective immunity evoked by locally administered group A streptococcal vaccines in mice.
    Bronze MS; McKinsey DS; Beachey EH; Dale JB
    J Immunol; 1988 Oct; 141(8):2767-70. PubMed ID: 3049817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Passive acquired mucosal immunity to group A streptococci by secretory immunoglobulin A.
    Bessen D; Fischetti VA
    J Exp Med; 1988 Jun; 167(6):1945-50. PubMed ID: 3290383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of intranasal immunization with synthetic peptides corresponding to conserved epitopes of M protein on mucosal colonization by group A streptococci.
    Bessen D; Fischetti VA
    Infect Immun; 1988 Oct; 56(10):2666-72. PubMed ID: 2458320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Recombinant fragments of conservative proteins of group B streptococci as a basis of specific vaccine].
    Suvorov AN; Grabovskaia KB; Leont'eva GF; Meringova LF; Koroleva IN; Duplik NV; Totolian AA
    Zh Mikrobiol Epidemiol Immunobiol; 2010; (2):44-50. PubMed ID: 20465000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective studies with group A streptococcal M protein vaccine. III. Challenge of volunteers after systemic or intranasal immunization with Type 3 or Type 12 group A Streptococcus.
    D'Alessandri R; Plotkin G; Kluge RM; Wittner MK; Fox EN; Dorfman A; Waldman RH
    J Infect Dis; 1978 Dec; 138(6):712-8. PubMed ID: 368261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Passive protection of mice against group A streptococcal pharyngeal infection by lipoteichoic acid.
    Dale JB; Baird RW; Courtney HS; Hasty DL; Bronze MS
    J Infect Dis; 1994 Feb; 169(2):319-23. PubMed ID: 8106764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intranasal vaccination with SfbI or M protein-derived peptides conjugated to diphtheria toxoid confers protective immunity against a lethal challenge with Streptococcus pyogenes.
    Schulze K; Olive C; Ebensen T; Guzmán CA
    Vaccine; 2006 Aug; 24(35-36):6088-95. PubMed ID: 16828529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.